期刊文献+

流感病毒核酸内切酶抑制剂高通量筛选模型的建立 被引量:3

Establishment of high throughput screening assay targeting the endonuclease activity of influenza virus PAN protein
原文传递
导出
摘要 目的:建立适于高通量筛选的流感病毒核酸内切酶(PAN)抑制剂筛选模型。方法:在大肠杆菌中诱导表达质粒,经蛋白纯化和浓缩,得到目的蛋白PAN。提取噬菌体M13K07的单链环状DNA为底物,应用荧光定量方法建立PAN抑制剂高通量筛选体系,并对应用虚拟筛选技术挑选的100个样品进行PAN抑制活性筛选。结果:反应体系在底物质量浓度0.2μg.mL-1,pH 9.0,Mn2+浓度1 mmol.L-1,37℃温孵60 min的条件下酶活性最佳。此时Z'因子为0.77,可用于高通量筛选。筛选结果发现7个样品对PAN具有抑制活性。结论:本研究建立的流感病毒核酸内切酶抑制剂高通量筛选体系可用于PAN抑制剂的筛选。 Objective : To establish a high throughput screening (HTS) assay for the endonuclease activity of influenza virus PAN protein. Methods: The plasmid pET-28a/PAN was constructed and transformed into Esche- richia coli to express PAN which was purified and concentrated next. The single-stranded circular DNA of phage M13K07 was prepared and used as a substrate (ph-DNA) of PAN endonuclease activity. The fluorescence quantita- tive method was applied to establish the HTS assay for PAN inhibitors, and then 100 samples selected by virtual screening strategy were evaluated. Results: PAN endonuclease had high reaction activity under the condition of O. 2 μg· mL-1 ph-DNA substrate, 1 mmol. L-1 Mn2+ , pH value 9.0, temperature 37 ℃ and reaction time 60 min. Z' factor was 0.77, indicating the assay could meet the HTS requirements, and the screening results showed that 7 samples displayed significant inhibitory activity on PAN. Conclusion: In this study, the HTS assay targeting the endonuclease activity of influenza virus PAN protein was established and optimized which was available for the screening of PAN inhibitors.
出处 《中国新药杂志》 CAS CSCD 北大核心 2013年第10期1137-1142,共6页 Chinese Journal of New Drugs
基金 国家"重大新药创制"科技重大专项(2012ZX09301002) 北京市自然基金(103172)
关键词 流感病毒 PAN.内切酶抑制剂 荧光定量方法 高通量筛选 influenza virus PAN endonuclease inhibitor fluorescence quantitative method high throughput screening
  • 相关文献

参考文献26

  • 1REID AH, TAUBENBERGER ]K, FANNING TG. The 1918 Spanish influenza : integrating history and biology [ ,/]. Microbes Infect, 2001, 3 ( 1 ) :81 - 87.
  • 2BOUVIER NM, PALESE P. The biology of influenza viruses[ J]. Vaccine, 2008, 26 ( Suppl 4) : $49 - $53.
  • 3ISON MG. Antivirals and resistance: influenza virus [ J]. Curr Opin Virol, 2011, 1:563-573.
  • 4HAYDEN F. Developing new antiviral agents for influenza treat- ment: what does the future hold? [ J]. Clin Infect Dis, 2009, 48(Supp!. 1) : $3 -$13.
  • 5LEYSSEN P, DE CLERCQ E, NEYTS J. Molecular strategies to inhibit the replication of RNA viruses [ J ]. Antiviral Res, 2008, 78(1): 9-25.
  • 6BOLTZ DA, ALDRIDGE J RJR, WEBSTERr RG, et al. Drugs in development for influenza[ J ]. Drugs, 2010, 70 ( 11 ) : 1349 - 1362.
  • 7DAS K, ARAMINIi JM, MA LC, et al. Structures of influenza A proteins and insights into antiviral drug targets [ J ]. Nat Strttct Mol Biol, 2010, 17(5) :530 -538.
  • 8HARA K, SCHMIDT FI, CROW M, et al. Amino acid residues in the N-terminal region of the PA subunlt of influenza a virus RNA polymerase play a critical role in protein stability, endonu- clease activity, cap binding, and virion RNA promoter binding [J]. J Virol, 2006, 80(16): 7789-7798.
  • 9DIAS A, BOUVIER D, CREPIN T, et al. The cap-snatching en- donuclease of influenza virus polymerase resides in the PA sub- unlt[J]. Nature, 2009, 458(7240) : 914 -918.
  • 10CREPIN T, DIAS A, PALENCIA A, et al. Mutational and metalbinding analysis of the endonuclease domain of the influenza virus polymerase PA subunit[J]. J Virol, 2010, 84(18) : 9096 -9104.

同被引文献44

  • 1NG Andy Ka-Leung,SHAW Pang-Chui.Structure and sequence analysis of influenza A virus nucleoprotein[J].Science China(Life Sciences),2009,52(5):439-449. 被引量:18
  • 2李洪林,沈建华,罗小民,沈旭,朱维良,王希诚,陈凯先,蒋华良.虚拟筛选与新药发现[J].生命科学,2005,17(2):125-131. 被引量:43
  • 3Hayden F.Developing new antiviral agents for influenza treatment:what does the future hold?[J].Clin Infect Dis,2009,48(Supplement 1):S3-S13.
  • 4Pizzorno A,Abed Y,Boivin G.Influenza drug resistance[C]//Seminars in respiratory and critical care medicine?Thieme Medical Publishers,2011,32(4):409-22.
  • 5Gutiérrez R A,Naughtin M J,Horm S V,et al.A(H5N1)virus evolution in South East Asia[J].Viruses,2009,1(3):335-61.
  • 6Boivin S,Cusack S,Ruigrok RW,et al.Influenza A virus polymerase:structural insights into replication and host adaptation mechanisms[J].J Biol Chem,2010,285(37):28411-7.
  • 7Fodor E.The RNA polymerase of influenza A virus:mechanisms of viral transcription and replication[J].Acta Virol,2012,57(2):113-22.
  • 8Hara K,Schmidt F I,Crow M,et al.Amino acid residues in the N-terminal region of the PA subunit of influenza A virus RNA polymerase play a critical role in protein stability,endonuclease activity,cap binding,and virion RNA promoter binding[J].J Virol,2006,80(16):7789-98.
  • 9Zheng W,Olson J,Vakharia V,et al.The crystal structure and RNA-binding of an orthomyxovirus nucleoprotein[J].Plos Pathogens,2013,9(9):e1003624.
  • 10Yuan P,Bartlam M,Lou Z,et al.Crystal structure of an avian influenza polymerase PANreveals an endonuclease active site[J].Nature,2009,458(7240):909-13.

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部